Results 11 to 20 of about 80,394 (203)

Recurrent pneumothorax in a human immunodeficiency virus-positive patient with multidrug-resistant tuberculosis: a rare case of bronchopleural fistula: a case report

Journal of Medical Case Reports, 2022
Background Human immunodeficiency virus/tuberculosis coinfections have amplified the multidrug-resistant tuberculosis pandemic in many countries in Sub-Saharan Africa, and multidrug-resistant tuberculosis has become a major public health threat. There is
Lydia Nakiyingi, Joseph Baruch Baluku, Willy Ssengooba, Sharon Miriam Namiiro, Paul Buyego, Ivan Kimuli, Susan Adakun   +6 more
doaj   +1 more source

Survey data of multidrug-resistant tuberculosis, Tuberculosis patients characteristics and stress resilience during COVID-19 pandemic in West Sumatera Province, Indonesia

Data in Brief, 2020
This set of data presents a survey data describing multidrug-resistant tuberculosis, tuberculosis patients characteristics and stress resilience during COVID-19 pandemic in West Sumatera Province, Indonesia.
Ricvan Dana Nindrea, Nissa Prima Sari, Wirsma Arif Harahap, Samuel J. Haryono, Hari Kusnanto, Iwan Dwiprahasto, Lutfan Lazuardi, Teguh Aryandono   +7 more
doaj   +1 more source

Economic evaluation of short treatment for multidrugresistant tuberculosis, Ethiopia and South Africa : the STREAM trial [PDF]

, 2020
OBJECTIVE STREAM was a phase-III non-inferiority randomised controlled trial (RCT) to evaluate a shortened regimen for multi-drug resistant tuberculosis (MDR-TB), and included the first-ever within-trial economic evaluation of such regimens, reported ...
Evans, Denise, Girma Tefera, Mamo, HASH(0x5574f3dd52e8), Langley, Ivor, Madan, Jason, Nunn, Andrew, Phillips, Patrick P. J., Rosu, Laura, Ruseng, I. D., Squire, S. Bertel, Tomeny, Ewan M., van Rensburg, Craig   +11 more
core   +4 more sources

Europe's contribution to the evaluation of the use of systemic antimicrobials in the treatment of periodontitis

Periodontology 2000, EarlyView., 2023
Abstract This narrative review celebrates Europe's contribution to the current knowledge on systemically administered antimicrobials in periodontal treatment. Periodontitis is the most frequent chronic noncommunicable human disease. It is caused by dysbiotic bacterial biofilms and is commonly treated with subgingival instrumentation.
David Herrera, Arie Jan van Winkelhoff, Paula Matesanz, Katalina Lauwens, Wim Teughels   +4 more
wiley   +1 more source

Drug-Resistant Tuberculosis--Current Dilemmas, Unanswered Questions, Challenges and Priority Needs [PDF]

, 2012
Tuberculosis was declared a global emergency by the World Health Organization (WHO) in 1993. Following the declaration and the promotion in 1995 of directly observed treatment short course (DOTS), a cost-effective strategy to contain the tuberculosis ...
Abubakar, Ibrahim, Atun, Rifat, Chakaya, Jeremiah, Cox, Helen, Ditiu, Lucica, Ford, Nathan, Grobusch, Martin, Hoelscher, Michael, Lawn, Stephen D., Maeurer, Markus, Marais, Ben, Mchugh, Timothy D., McNerney, Ruth, Memish, Ziad, Migliori, Giovanni-Battista, Mwaba, Peter, O'Grady, Justin, Pletschette, Michel, Ramsay, Andrew, Raviglione, Mario, Schito, Marco, Squire, S. Bertel, Swaminathan, Soumya, Zumla, Alimuddin   +23 more
core   +1 more source

Prevalence of multidrug-resistant tuberculosis in East Africa: A systematic review and meta-analysis.

PLoS ONE, 2022
BackgroundThe rate of multidrug-resistant tuberculosis is increasing at an alarming rate throughout the world. It is becoming an emerging public health problem in East Africa.
Kindu Alem Molla, Melese Abate Reta, Yonas Yimam Ayene   +2 more
doaj   +1 more source

Multidrug-resistant tuberculosis in middle ear: A case report

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2023
Background: Tuberculosis (TB) continues to be a common disease in developing countries, among which middle ear TB is rare. Furthermore, it is relatively difficult to make an early diagnosis and provide follow-up treatment for middle ear TB.
Tanze Cao, Xiuping Liu, Chengqing Yang, Chunlin Mei, Jiali Ou, Ronghui Du   +5 more
doaj   +1 more source

Microscopic-observation drug-susceptibility assay for the diagnosis of TB. [PDF]

, 2006
BACKGROUND: New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and multidrug-resistant tuberculosis. Rapid, sensitive detection of tuberculosis and multidrug-resistant tuberculosis in sputum has been demonstrated in ...
Caviedes, Luz, Coronel, Jorge, Escombe, A Roderick, Evans, Carlton AW, Friedland, Jon S, Gilman, Robert H, Hollm-Delgado, Maria-Graciela, LaChira, Doris, Moore, David AJ, Oberhelman, Richard, Piñedo, Yvette, Salazar, Cayo, Sanchez, Eduardo, Saravia, Juan Carlos, Vivar, Aldo   +14 more
core   +1 more source

Multidrug-resistant tuberculosis today [PDF]

Bulletin of the World Health Organization, 2012
The World Health Organization (WHO) and its partners have long conducted efforts to improve tuberculosis (TB) case surveillance and programme monitoring and evaluation. WHO’s 2011 report on global TB control1 provided the most reliable information ever generated on the burden of disease and death caused by TB and multidrug-resistant TB (i.e.
Matteelli, A., Centis, R., D'Ambrosio, L., Migliori, G. B.   +3 more
openaire   +4 more sources

Household screening and multidrug-resistant tuberculosis [PDF]

, 2010
Of the estimated half a million people who develop multidrug resistant (MDR) tuberculosis each year, less than 7% are diagnosed and only 1 in 5 of these have access to eff ective treatment.1 To control this epidemic, dramatically increased efforts are ...
Becerra, Gilles van Cutsem, Helen Cox, Keshavjee, Lin, London, Mitnick, Mitnick, Morán-Mendoza, Rieder   +9 more
core   +2 more sources